Cystic Fibrosis Foundation - Click here for homepage
Stay Informed  |  Volunteer  |  Clinical Trials

In This Section

Quick Links

Find a Chapter

Get Assistance

Get Assistance - Cox Boys
We are here to help people with CF get the insurance coverage they need. Hear how the Foundation helped the Cox family.

Join us on Facebook!  Facebook 
Follow us on Twitter!   Twitter
Follow us on Instagram!  Instagram 
Add us to your circle in Google+!


Subscribe to our channel on YouTube!  YouTube  




CF Foundation President & CEO Talks with Lead Investigator of
VX-770 Clinical Trials

October 24, 2008

Among the exciting updates announced at the CF Foundation’s 22nd annual North American Cystic Fibrosis Conference this week in Orlando, Fla., is news of the most recent Phase 2a study of Vertex Pharmaceuticals, Inc.’s compound VX-770, which aims to treat the basic defect in CF.

Robert J. Beall, Ph.D., president and CEO of the Foundation, joined Frank Accurso, M.D., director of the CF care center at the Children’s Hospital in Denver, Colo. and principal investigator of VX-770’s clinical trials, to discuss the exciting news.

Watch here to learn more about VX-770.

The Cystic Fibrosis Foundation is an accredited charity of the Better Business Bureau.